UNSPSC 51203101: Ciclosporin or cyclosporine

This classification denotes a multidrug resistance modulator and immunosuppressant with the molecular formula C62H111N11O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 83HN0GTJ6D, chemically known as cyclosporin a, tolypocladium inflatum but more generally known as ciclosporin, which bears US NIH Compound Identifier 5280754. European Medicines Agency schedules Ciclosporin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06250MIG.

UNSPSC 51203101 Ciclosporin or cyclosporine is a Commodity code, but the recent state and local opportunities posted under it show little activity aligned with the code's nominal scope. The two most recent records—an Illinois Department of Public Health piggyback pharmaceutical contract and a Seminole County, Florida procurement—are tagged to this code but actually cover Doxycycline Hyclate, Ciprofloxacin Hydrochloride, Naloxone, and drug deactivation systems, none of which are ciclosporin or cyclosporine. State and local procurement systems occasionally misclassify pharmaceutical solicitations, and this code appears to reflect that pattern rather than a substantive market for ciclosporin procurement at the state or local level.

The limited recent activity here does not support a meaningful pursue recommendation. The Illinois Department of Public Health awarded a completed piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 for antibiotics (Doxycycline and Ciprofloxacin), and Seminole County posted an IFB for Naloxone and drug deactivation systems with a due date of July 26, 2023. Neither opportunity is active, and neither involves ciclosporin or cyclosporine products. If your firm specializes in immunosuppressant pharmaceuticals or organ-transplant-related medications, monitor this code for reclassification or future activity, but do not expect consistent volume or clarity of scope under the current tagging structure.